RN
TransCode Therapeutics
RNAZ·NASDAQBoston MAFounded 201615 employees
Micro CapbiotechPublicOncology
Platform: RNA Nano Onc
Market Cap
$0.01B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (RNAZ)
Loading RNAZ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tezevorutinib | RNA-172 | Approved | 1 | SHP2 | Angelman | ||
| Mavuinavolisib | RNA-543 | Preclinical | 2 | VEGF | CSUGBM |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)